SCHEMBL5658941

SCHEMBL5658941

OCc1ccccc1Sc1cccc2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IFNAR1 P17181 1/20 0.65
LMNA P02545 3/20 0.63
ALDH1A1 P00352 3/20 0.63
MAPK1 P28482 2/20 0.63
NPY1R P25929 1/20 0.63
NPY2R P49146 1/20 0.63
APOBEC3G Q9HC16 1/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
MAPT P10636 1/20 0.55
RAD52 P43351 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
RECQL P46063 1/20 0.55
NLRP3 Q96P20 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
SLC6A4 P31645 5/20 0.46
TDP1 Q9NUW8 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4442278 0.85 APOBEC3G (0.73) IFNAR1LMNAALDH1A1MAPK1NPY1R
SCHEMBL577858 0.83 IFNAR1 (0.60) IFNAR1LMNAALDH1A1MAPK1NPY1R
SCHEMBL31167972 0.83 IFNAR1 (0.60) IFNAR1LMNAALDH1A1MAPK1NPY1R
SCHEMBL5661131 0.83 IFNAR1 (0.63) IFNAR1LMNAALDH1A1MAPK1NPY1R
SCHEMBL4440541 0.82 APOBEC3G (0.48) IFNAR1LMNAALDH1A1MAPK1NPY1R
SCHEMBL5658529 0.82 TDP1 (0.69) IFNAR1LMNAALDH1A1MAPK1NPY1R
SCHEMBL30548749 0.81 IFNAR1 (0.58) IFNAR1LMNAALDH1A1MAPK1NPY1R
SCHEMBL5659156 0.79 IFNAR1 (0.62) IFNAR1LMNAALDH1A1MAPK1NPY1R
SCHEMBL30996076 0.79 IFNAR1 (1.00) IFNAR1LMNAALDH1A1MAPK1NPY1R
Hydrochloric Acid SCHEMBL30725687 0.78 IFNAR1 (0.97) IFNAR1LMNAALDH1A1MAPK1NPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262309-B2 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof GLAXOSMITH KLINE ISTRAZIVOCKI CENTAR ZAGREB, D.O.O. (HR) 2007-08-28 US disclosed
EP-1492795-B1 1- OR 3-THIA-BENZONAPHTHOAZULENES AS INHIBITORS OF TUMOUR NECROSIS FACTOR PRODUCTION AND INTERMEDIATES FOR THE PREPARATION THEREOF PLIVA ISTRAZIVACKI INST D O O (HR) 2005-11-16 EP disclosed
US-20050137249-A1 1-or 3-thia-benznaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof PLIVA-ISTRAZIVACKI INSTITUT D.D.D. (HR) 2005-06-23 US disclosed
US-20050130964-A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2005-06-16 US disclosed
EP-1492795-A1 1- OR 3-THIA-BENZONAPHTHOAZULENES AS INHIBITORS OF TUMOUR NECROSIS FACTOR PRODUCTION AND INTERMEDIATES FOR THE PREPARATION THEREOF PLIVA-ISTRAZIVACKI INSTITUT d.o.o. (HR) 2005-01-05 EP disclosed
WO-2003084961-A1 1- OR 3-THIA-BENZONAPHTHOAZULENES AS INHIBITORS OF TUMOUR NECROSIS FACTOR PRODUCTION AND INTERMEDIATES FOR THE PREPARATION THEREOF PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2003-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130964-A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof TNF, IL1A, IL1B IFNAR1 430/4885LMNA 3718/4885ALDH1A1 86/4885
US-20050137249-A1 1-or 3-thia-benznaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof TNF, IL1A, IL1B IFNAR1 289/4885LMNA 2813/4885ALDH1A1 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.